Treatment

Riociguat Bayer, Riociguat Bayer, Riociguat Bayer, Riociguat Bayer, Riociguat Bayer clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingTherapeutic use (Phase IV)
An open-label, prospective, single centre study of the effects of Riociguat on RIght VEntricular size and function in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
This study looks at how a medicine called Riociguat affects the right side of the heart in people with pulmonary hypertension. Researchers want to see if it changes the size and function of the heart's right chambers over 24 weeks.
For: Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Arterial Hypertension
Germany